Literature DB >> 7819899

Effect of non-attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. Family Heart Study Group.

G Davies1, S Pyke, A L Kinmonth.   

Abstract

OBJECTIVES: To determine the feasibility of enrolling non-attenders of a population based cardiovascular risk reduction programme (the British family heart study) into a further, similar programme and to assess the effect of non-attendance on the effectiveness of the programme.
DESIGN: Follow up of non-attenders by practice nurses, including home visits if necessary, to administer questionnaires and obtain physiological measurements.
SETTING: Eight general practices across England, Scotland, and Wales.
SUBJECTS: Non-attenders in a cardiovascular risk factor screening and intervention programme compared with attenders. MAIN OUTCOME MEASURES: Number of non-attenders enrolled; sociodemographic characteristics; personal and family history of coronary heart disease; cardiovascular risk factors; and total coronary risk score.
RESULTS: Data were collected from 106 (17%) of the 608 non-attending families (99 men and 42 women). Of the 543 non-attending families from five practices that attempted complete follow up, 256 had moved away or died. Only 76 were eventually enrolled into the study. The prevalence of coronary heart disease and a family history of coronary heart disease were similar among non-attenders and attenders as were the individual coronary risk factors studied except smoking. Women non-attenders were more likely to be current cigarette smokers than attenders (15/42 v 202/948, P = 0.02).
CONCLUSIONS: The intensive follow up of non-attenders resulted in real intervention opportunities in only a small number. Since the effect of any intervention in a population is reduced by non-attendance audit of preventive medical programmes aimed at the population should allow for the effect of non-attenders on the overall results.

Entities:  

Mesh:

Year:  1994        PMID: 7819899      PMCID: PMC2541730          DOI: 10.1136/bmj.309.6968.1553

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  6 in total

1.  Action plan for preventing coronary heart disease.

Authors:  A L Kinmonth; G Davies
Journal:  BMJ       Date:  1991-10-26

2.  Continuous opportunistic and systematic screening for hypertension with computer help: analysis of non-responders.

Authors:  F Difford; J P Telling; K R Davies; J E Fornear; C A Reading
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-02

3.  Differences between respondents and non-respondents in a population-based cardiovascular disease study.

Authors:  M H Criqui; E Barrett-Connor; M Austin
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

4.  The Dundee coronary risk-disk for management of change in risk factors.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1991-09-28

5.  Coronary heart disease: account of a preventive clinic in general practice.

Authors:  J G Wrench; R Irvine
Journal:  J R Coll Gen Pract       Date:  1984-09

6.  Invitation to attend a health check in a general practice setting: comparison of attenders and non-attenders.

Authors:  R Pill; J French; K Harding; N Stott
Journal:  J R Coll Gen Pract       Date:  1988-02
  6 in total
  11 in total

Review 1.  Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies.

Authors:  M McKee; A Britton; N Black; K McPherson; C Sanderson; C Bain
Journal:  BMJ       Date:  1999-07-31

2.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.

Authors:  R K Simmons; M Rahman; R W Jakes; M F Yuyun; A R Niggebrugge; S H Hennings; D R R Williams; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

Review 3.  Effectiveness of general practice-based health checks: a systematic review and meta-analysis.

Authors:  Si Si; John R Moss; Thomas R Sullivan; Skye S Newton; Nigel P Stocks
Journal:  Br J Gen Pract       Date:  2014-01       Impact factor: 5.386

4.  Feasibility of a men's health promotion programme in Irish primary care.

Authors:  A McMahon; M Hodgins; C C Kelleher
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

5.  Randomised controlled trial to examine the effects of a GP exercise referral programme in Hailsham, East Sussex, on modifiable coronary heart disease risk factors.

Authors:  A H Taylor; J Doust; N Webborn
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

6.  Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study.

Authors:  Parinya Chamnan; Rebecca K Simmons; Kay-Tee Khaw; Nicholas J Wareham; Simon J Griffin
Journal:  BMJ       Date:  2010-04-23

7.  General health checks in adults for reducing morbidity and mortality from disease.

Authors:  Lasse T Krogsbøll; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2019-01-31

8.  Who wants to join preventive trials?--Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].

Authors:  Sirpa-Liisa Hovi; Matti Hakama; Piret Veerus; Mati Rahu; Elina Hemminki
Journal:  BMC Med Res Methodol       Date:  2005-04-12       Impact factor: 4.615

9.  Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: A systematic review.

Authors:  Anne-Karien M de Waard; Per E Wändell; Martin J Holzmann; Joke C Korevaar; Monika Hollander; Carl Gornitzki; Niek J de Wit; François G Schellevis; Christos Lionis; Jens Søndergaard; Bohumil Seifert; Axel C Carlsson
Journal:  Eur J Prev Cardiol       Date:  2018-06-19       Impact factor: 7.804

10.  Community participation and sustainability--evidence over 25 years in the Västerbotten Intervention Programme.

Authors:  Margareta Norberg; Yulia Blomstedt; Göran Lönnberg; Lennarth Nyström; Hans Stenlund; Stig Wall; Lars Weinehall
Journal:  Glob Health Action       Date:  2012-12-17       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.